Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study

Muhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, Ralph A. DeFronzo, Ebaa Al-Ozairi, Amin Jayyousiv

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study'. Together they form a unique fingerprint.

Medicine & Life Sciences